Veterans Intensive Personalized Treatment in Heart Failure
VIP
VIP (Veterans Intensive Personalized) Treatment in Heart Failure
1 other identifier
interventional
99
1 country
1
Brief Summary
In the VIP (Veterans Intensive Personalized) Treatment in Heart Failure Study we will assess 2 novel interventions to enhance adherence and improve quality of life in veterans with heart failure. This 3-arm randomized controlled trial will base one active arm on how ready patients are for change in terms of diet and medication adherence and will tailor the intervention based on this. The other active arm will also assess how ready patients are for change, but will also include tailoring based on availability of environment resources, such as proximity to health food stores or social support, to further tailor the intervention. The last active arm is simply an attention group where patients will receive general health counseling in addition to background care that all patients receive. The overarching hypothesis is that the tailored interventions will lower heart failure (HF) recurrence and improve quality of life by better medication and diet adherence compared to attention placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Nov 2011
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2011
CompletedFirst Posted
Study publicly available on registry
July 28, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedResults Posted
Study results publicly available
May 25, 2015
CompletedMay 25, 2015
May 1, 2015
2.1 years
July 27, 2011
February 23, 2015
May 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication Adherence (Refill Compliance for All HF Medications)
Refill compliance is an objective measurement of medication adherence that utilizes pharmacy records to assess the proportion of time a patient has medication available to take. At the original release of the medication, and each subsequent refill, individuals are given enough medication to last a set number of days. This number is referred to as the "Days Supply" and can be calculated by dividing the number of pills prescribed by the number of pills taken per day. To calculate compliance, the "Days Supply" is subtracted by the number of days between Actual Refill dates, a time span referred to as the "Days Passed". If the Days Passed exceeds the Days Supply the absolute value of the difference represents the number of days the individual was non-adherent. This absolute value is referred to as a "Gap". The sum of the Gaps/total number of days passed between the original release of the medication and the final recorded refill date represents non-compliance over that period of time.
6 months from baseline visit
Secondary Outcomes (3)
Adherence to ACE Inhibitors and ARB
6 months after baseline
Adherence to Beta Blockers
6 months from baseline
Self-reported Medication Adherence
6 months from baseline
Study Arms (3)
Telephone-Delivered BI
EXPERIMENTALComprehensive behavioral intervention (BI) - Participants will receive the BI that is based on the transtheoretical model, which targets stage of change, decisional balance and self-efficacy, while also assessing and counseling regarding the barriers and facilitators of HF care, and to improve self-regulatory care such as self-monitoring, self-evaluation, feedback and reinforcement.
Telephone-Delivered BEI
EXPERIMENTALBehavioral \& Environmental Intervention (BEI) - Participants in this arm will receive the BI but will also receive environmental tailoring. Environmental Tailoring consists of Built Environment Tailoring (BET) where the intervention will incorporate aspects from the patients' environment, such as accessibility of health food stores or recreational facilities. Environmental Tailoring also consists of Human Environment Tailoring (HET) which incorporates patients' social support. Caregivers will be enrolled for patients in this arm of the study and they will also receive health education.
Telephone-Delivered API
PLACEBO COMPARATORAttention Placebo Intervention (API) - patients will receive non-tailored counseling on general health topics.
Interventions
Behavioral Intervention will be delivered over the phone.
Behavioral and Environmental Intervention will be delivered over the phone
Attention Placebo Intervention will be delivered over the phone
Eligibility Criteria
You may qualify if:
- Men and women (21 years) with history and clinical findings of chronic, stable HF of NYHA functional class I (previously symptomatic/now asymptomatic), II, or III.
- They must have an available phone and 2 clinic visits in the previous 1.5 years.
You may not qualify if:
- Patients with poor short-term survival (\< 1 year)
- recent major surgery (\< 3 months)
- temporarily in the area
- or those unable to provide consent will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA New York Harbor Health Care System
New York, New York, 10010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sundar Natarajan, MD, M.Sc.
- Organization
- VA New York Harbor Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Sundar Natarajan, MD MSc
VA New York Harbor Health Care System
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2011
First Posted
July 28, 2011
Study Start
November 1, 2011
Primary Completion
December 1, 2013
Study Completion
June 1, 2014
Last Updated
May 25, 2015
Results First Posted
May 25, 2015
Record last verified: 2015-05